Implementing standardized STD follow-up trainings to advance STD prevention and control in clinical settings
The trainings included local STD epidemiology, screening and treatment guidelines, positive patient communication, confidential morbidity reporting, as well as an interactive activity on partner elicitation. CHFC conducted evaluations immediately after the training sessions to assess knowledge, attitudes, and behavior intent for STD prevention and control. In an effort to assess the efficacy of the trainings, a six-month follow-up survey was administered to the participants. Evaluation findings will be used to improve the curriculum of the STD positive follow-up trainings, and shared with participating healthcare agencies to enhance STD prevention and control.
This session will review best practices in STD positive patient management and lessons learned in systems change affecting policy and practice, fast tracking appointments, training key staff, and implementing sustainable protocols can lead to better positive patient management.
Protection of the public in relation to communicable diseases including prevention or control
Public health or related education
Identify strategies that address challenges and the need for STD positive patient management. Discuss monitoring activates required to ensure successful implementation of STD positive patient management. Formulate system changes that positively influence the effectiveness of STD positive patient management.
Keywords: STD, Reproductive Health
Qualified on the content I am responsible for because: I am the Director of Community-Based STI Prevention Initiatives, focusing on clinical and community strategies to address STD prevention and control. I have ten years of experience working in the field of infectious disease and public health. I led the design, coordination, and implementation of the trainings.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.